Showing 19,181 - 19,200 results of 105,180 for search '(( 2 fold decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.67s Refine Results
  1. 19181
  2. 19182

    S1 Data - by Zixiang Wang (7548716)

    Published 2024
    “…The two groups of rats were observed and compared for PVT formation at 1, 3 and 5 days after modeling, respectively.</p><p>Results</p><p>A stable rat PVT model was successfully constructed. …”
  3. 19183
  4. 19184
  5. 19185
  6. 19186
  7. 19187
  8. 19188
  9. 19189
  10. 19190
  11. 19191
  12. 19192
  13. 19193

    Image5_Investigating Effect of Coherent Emission Length on Pion Interferometry in High-Energy Collisions Using a Multiphase Transport Model.EPS by Shi-Yao Wang (12521500)

    Published 2022
    “…<p>We study the two-pion Hanbury Brown–Twiss correlation functions for a partially coherent source constructed with the emission points and momenta of the identical pions generated by a multiphase transport model. …”
  14. 19194
  15. 19195

    eGFR trajectories by type of physical activity. by Ronit Calderon-Margalit (584756)

    Published 2025
    “…</p><p>Results</p><p>During 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m<sup>2</sup> per year. …”
  16. 19196
  17. 19197
  18. 19198

    DataSheet1_Effect of CYP3A4 Inhibitors and Inducers on Pharmacokinetics and Pharmacodynamics of Saxagliptin and Active Metabolite M2 in Humans Using Physiological-Based Pharmacokin... by Gang Li (34549)

    Published 2021
    “…The predictions also showed that although PK profiles of saxagliptin showed significant changes with delavirdine (AUC 1.5-fold increase) or rifampicin (AUC: a decrease to 0.19-fold) compared to those without inhibitors or inducers, occupancies of DPP-4 by saxagliptin were nearly unchanged, that is, the administration dose of saxagliptin need not adjust when there is coadministration with delavirdine or rifampicin.…”
  19. 19199
  20. 19200